Did any adverse reactions happen during this study?

Tacrolimus, Cyclosporin, SZC, and participants had adverse reactions as follows: 

- Tacrolimus: 6.5% (2 out of 31 participants)
- Cyclosporin: 23.3% (7 out of 30 participants)
- SZC: 6.5% (2 out of 31 participants)
- Cyclosporin: 6.9% (2 out of 29 participants)

How many participants had serious adverse reactions?

- None

How many participants stopped taking study treatment due to adverse reactions?

- None

What serious adverse reactions happened during this study?

No serious adverse reactions happened during this study.